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INTRODUCTION:
Premature Ejaculation (PE) is a sexual dysfunction that concern 20-30% of the male population. 
Dapoxetine is a new serotonine re-uptake inhibitor (SSRI), the only commercial formulation for the specific treatment of PE. Primary 
 aim of the study is the assessment of compliance and the effectiveness of the treatment with dapoxetine 
compared to the treatment with citalopram, a classic SSRI in a group of selected patients with PE. 
MATERIAL AND METHODS:
We selected a sample of 334 male patients aged between 18 and 64 years who 
reported EP from the outpatient clinic male population of our departement. 
Intravaginal latency time (IELT) was less than 2 minutes in 233 patients (70%). Of 
the 233 patients, 134 patients (57%) were pharmacologically elegible and among 
them 118 (50,64%) agreed to entry in our study. This sample was divided into 2 
groups: 82 (70%) patients received dapoxetine(30 or 60mg)  while 36 (30%) 
received Citalopram (up to 20-30 mg, 10-20 drops)prescription when Dapoxetine 
was controindicated. Our protocol envisage periodical visit to analyse compliance 
and effectiveness at 0, 1st , 3rd and 6th  month.
RESULTS:
Of the 82 patients treated with Dapoxetine compliance to 
treatment was good in 20 (24%), poor in 26 (32%), and absent 
in 36 (44%) patients respectively. In the 36
 patients treated with Citalopram, treatment compliance was 
good in 12 patients (33%), it was poor in 10 (28%) and it was 
absent in 14 (39%). The drop-out in the two groups was 23.6% 
(50 patients) without any statistical correlation between type 
of medication and quality of compliance.  In 68 patients fully 
evaluable was recordered the effectiveness of the treatment: 
Dapoxetine was effective in 86% of cases versus 75% of 
Citalopram according to the patient satisfaction. The 
occurrence of side effects was observed in 32% of cases: in 
17% of patients treated with Dapoxetine and in 15% of 
patients treated with Citalopram. However, side effects were 
generally mild and self-limiting, and occurred just at the first 
intake in about 90% of treated with Dapoxetine. 
CONCLUSIONS:
In our experience, dapoxetine in the treatment of PE was 
effective and well tolerated. Compliance to treatment has 
not appeared particularly high. It is hypothesized that this 
depends mostly by patient factors. Thus, it is right to 
emphasize that the assessment of  compliance to on-
demand treatment for EP, suffers from a limit that can not 
be corrected by the doctor because it depends on patients' 
linked factors ( educational, economical, affective status et 
al.). The goal to improve treatment compliance could be 
reached increasing, trought a better education and 
information, the involvement of patient in the treatment.
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